Skip to main content
OpenTrials
Completed

NCT Number: NCT01378819

3-midline-ports Cholecystectomy

The 3-midline-ports technique is a safety approach and associates lower postoperative pain, when compared with the standard "French" technique.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The patients will be randomized into 2 groups: those patients undergoing laparoscopic cholecystectomy following the "French" technique (Group 1) and those ones undergoing the 3-midline-ports approach (Group 2).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing elective cholecystectomy for symptomatic gallstones.

Exclusion criteria

  • Diagnosis of acute cholecystitis

Treatment and study plan

3-midline-ports laparoscopic cholecystectomy

Procedure

The laparoscopic cholecystectomy will be performed through 3 ports placed in the line alba.

Primary outcomes

  1. Postoperative pain

    Time frame: 24 hours

    The postoperative pain will be investigated 24 hours after surgery

Sponsors and collaborators

Lead sponsor

Universidad Miguel Hernandez de Elche

Other

Registry information

Official study title

Three Ports Placed in the Line Alba of the Abdomen (3-midline-ports Technique): an Alternative Approach for Laparoscopic Cholecystectomy

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Jun 22, 2011
Registry last updated
Jun 22, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.